|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Idiopathic Thrombocytopenic Purpura | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Purpura | |||||
| Purpura, Thrombocytopenic | |||||
| Purpura, Thrombocytopenic, Idiopathic | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Blood Coagulation Disorders | |||||
| Blood Platelet Disorders | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Immune System Diseases | |||||
| Signs and Symptoms | |||||
| Skin Manifestations | |||||
| Thrombocytopenia | |||||
| 4 | Interventions listed in this trial | ||||
| IGIV3I Grifols | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Immunoglobulins, Intravenous | |||||
| 6 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 7 | Sponsors listed in this trial | ||||
| Grifols Biologicals Inc. | |||||